Lymphocyte arginase activity in leprosy--a preliminary report.
Arginase activity was estimated in serum and lymphocytes of 22 healthy controls and 50 untreated leprosy patients across the spectrum. The patients included 21 lepromatous/borderline lepromatous (LL/BL); 20 borderline borderline/borderline tuberculoid (BB/BT) and 9 tuberculoid (TT) cases. Mean serum arginase levels were 1.51 +/- 0.43, 1.41 +/- 0.43, 1.24 +/- 0.43 and 1.10 +/- 0.026 mu moles/min/ml in LL/BL, BB/BT and TT patients and healthy controls respectively. The lymphocyte arginase activity showed a similar increasing trend from TT to LL/BL. The mean lymphocyte arginase levels were 0.87 +/- 0.31 mu moles/min/10(6) cells in healthy controls and 1.81 +/- 0.40, 2.54 +/- 0.60 and 5.48 +/- 0.56 mu moles/min/10(6) cells in TT, BB/BT and LL/BL patients respectively. The increasing trend specially in lymphocyte arginase levels across the spectrum of leprosy correlated with the degree of impairment in the protective cell mediated immune response and also the extent of disease. The role of these pathophysiological alterations in relation to defect in immune response calls for investigation.
Central JALMA Institute for Leprosy, Agra.
C S
CS
Babu
K B
KB
Kannan
V P
VP
Bharadwaj
V M
VM
Katoch
D001119:Arginase / Q000097:blood*; D006801:Humans; D015439:Leprosy, Borderline / Q000201:enzymology*; D015440:Leprosy, Lepromatous / Q000201:enzymology*; D015441:Leprosy, Tuberculoid / Q000201:enzymology*; D008214:Lymphocytes / Q000201:enzymology*
D001119:Arginase